Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
Authors
Keywords
-
Journal
Nature Communications
Volume 9, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-02
DOI
10.1038/s41467-018-02915-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanoparticle systems reduce systemic toxicity in cancer treatment
- (2016) Hai Wang et al. Nanomedicine
- 3D porous chitosan–alginate scaffolds promote proliferation and enrichment of cancer stem-like cells
- (2016) Stephen J. Florczyk et al. Journal of Materials Chemistry B
- Chitosan-Decorated Doxorubicin-Encapsulated Nanoparticle Targets and Eliminates Tumor Reinitiating Cancer Stem-like Cells
- (2015) Wei Rao et al. ACS Nano
- A Near-Infrared Laser-Activated “Nanobomb” for Breaking the Barriers to MicroRNA Delivery
- (2015) Hai Wang et al. ADVANCED MATERIALS
- Hyaluronic acid-decorated dual responsive nanoparticles of Pluronic F127, PLGA, and chitosan for targeted co-delivery of doxorubicin and irinotecan to eliminate cancer stem-like cells
- (2015) Hai Wang et al. BIOMATERIALS
- Heat shock factor 1 induces cancer stem cell phenotype in breast cancer cell lines
- (2015) Bin Wang et al. BREAST CANCER RESEARCH AND TREATMENT
- Using Hollow Carbon Nanospheres as a Light-Induced Free Radical Generator To Overcome Chemotherapy Resistance
- (2015) Liming Wang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Mutant p53 – Heat Shock Response Oncogenic Cooperation: A New Mechanism of Cancer Cell Survival
- (2015) Evguenia M. Alexandrova et al. Frontiers in Endocrinology
- Targeting Oncogenic Mutant p53 for Cancer Therapy
- (2015) Alejandro Parrales et al. Frontiers in Oncology
- Enhanced enrichment of prostate cancer stem-like cells with miniaturized 3D culture in liquid core-hydrogel shell microcapsules
- (2014) Wei Rao et al. BIOMATERIALS
- Manganese dioxide core–shell nanowires in situ grown on carbon spheres for supercapacitor application
- (2014) Xingming Zhang et al. CRYSTENGCOMM
- Improving Conventional Enhanced Permeability and Retention (EPR) Effects; What Is the Appropriate Target?
- (2014) Hisataka Kobayashi et al. Theranostics
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- The HSP70 family and cancer
- (2013) M. E. Murphy CARCINOGENESIS
- Targeting cancer cell mitochondria as a therapeutic approach
- (2012) Shijun Wen et al. Future Medicinal Chemistry
- Role of monocarboxylate transporters in human cancers: state of the art
- (2012) Céline Pinheiro et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- Nicastrin regulates breast cancer stem cell properties and tumor growth in vitro and in vivo
- (2012) Y. Lombardo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles
- (2011) Hai Wang et al. BIOMATERIALS
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer
- (2011) S. Santagata et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MCF-7/ADR cells (re-designated NCI/ADR-RES) are not derived from MCF-7 breast cancer cells: a loss for breast cancer multidrug-resistant research
- (2010) Weifeng Ke et al. MEDICAL ONCOLOGY
- The production of carbon materials by hydrothermal carbonization of cellulose
- (2009) M. Sevilla et al. CARBON
- A Two-Step Hydrothermal Synthesis Approach to Monodispersed Colloidal Carbon Spheres
- (2009) Chuyang Chen et al. Nanoscale Research Letters
- Therapeutic Nanoparticles for Drug Delivery in Cancer
- (2008) K. Cho et al. CLINICAL CANCER RESEARCH
- Nanoparticle therapeutics: an emerging treatment modality for cancer
- (2008) Mark E. Davis et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started